Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

ARUK Consortium; GERAD/PERADES, CHARGE, ADGC, EADI; International Genomics of Alzheimer's Project (IGAP); ARUK Consortium; GERAD/PERADES, CHARGE, ADGC, EADI

doi:10.1016/j.dadm.2018.08.008

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

ARUK Consortium, GERAD/PERADES, CHARGE, ADGC, EADI, International Genomics of Alzheimer's Project (IGAP), ARUK Consortium, GERAD/PERADES, CHARGE, ADGC, EADI

Research output: Contribution to journal › Article › peer-review

Abstract

Introduction: There is conflicting evidence whether high-density lipoprotein cholesterol (HDL-C) is a risk factor for Alzheimer's disease (AD) and dementia. Genetic variation in the cholesteryl ester transfer protein (CETP) locus is associated with altered HDL-C. We aimed to assess AD risk by genetically predicted HDL-C. Methods: Ten single nucleotide polymorphisms within the CETP locus predicting HDL-C were applied to the International Genomics of Alzheimer's Project (IGAP) exome chip stage 1 results in up 16,097 late onset AD cases and 18,077 cognitively normal elderly controls. We performed instrumental variables analysis using inverse variance weighting, weighted median, and MR-Egger. Results: Based on 10 single nucleotide polymorphisms distinctly predicting HDL-C in the CETP locus, we found that HDL-C was not associated with risk of AD (P >.7). Discussion: Our study does not support the role of HDL-C on risk of AD through HDL-C altered by CETP. This study does not rule out other mechanisms by which HDL-C affects risk of AD.

Original language	English (US)
Pages (from-to)	595-598
Number of pages	4
Journal	Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Volume	10
DOIs	https://doi.org/10.1016/j.dadm.2018.08.008
State	Published - Jan 1 2018

Keywords

Cholesteryl ester transfer protein
Genetics
HDL-C
Instrumental variables
Single nucleotide polymorphisms

ASJC Scopus subject areas

Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1016/j.dadm.2018.08.008

Cite this

ARUK Consortium, GERAD/PERADES, CHARGE, ADGC, EADI, International Genomics of Alzheimer's Project (IGAP), ARUK Consortium, & GERAD/PERADES, CHARGE, ADGC, EADI (2018). Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 10, 595-598. https://doi.org/10.1016/j.dadm.2018.08.008

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. / ARUK Consortium; GERAD/PERADES, CHARGE, ADGC, EADI; International Genomics of Alzheimer's Project (IGAP) et al.
In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 10, 01.01.2018, p. 595-598.

Research output: Contribution to journal › Article › peer-review

ARUK Consortium, GERAD/PERADES, CHARGE, ADGC, EADI, International Genomics of Alzheimer's Project (IGAP), ARUK Consortium & GERAD/PERADES, CHARGE, ADGC, EADI 2018, 'Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease', Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, vol. 10, pp. 595-598. https://doi.org/10.1016/j.dadm.2018.08.008

ARUK Consortium, GERAD/PERADES, CHARGE, ADGC, EADI, International Genomics of Alzheimer's Project (IGAP), ARUK Consortium, GERAD/PERADES, CHARGE, ADGC, EADI. Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 2018 Jan 1;10:595-598. doi: 10.1016/j.dadm.2018.08.008

ARUK Consortium ; GERAD/PERADES, CHARGE, ADGC, EADI ; International Genomics of Alzheimer's Project (IGAP) et al. / Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. In: Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 2018 ; Vol. 10. pp. 595-598.

@article{af2447be962547b2a52c29b0d6070916,

title = "Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease",

abstract = "Introduction: There is conflicting evidence whether high-density lipoprotein cholesterol (HDL-C) is a risk factor for Alzheimer's disease (AD) and dementia. Genetic variation in the cholesteryl ester transfer protein (CETP) locus is associated with altered HDL-C. We aimed to assess AD risk by genetically predicted HDL-C. Methods: Ten single nucleotide polymorphisms within the CETP locus predicting HDL-C were applied to the International Genomics of Alzheimer's Project (IGAP) exome chip stage 1 results in up 16,097 late onset AD cases and 18,077 cognitively normal elderly controls. We performed instrumental variables analysis using inverse variance weighting, weighted median, and MR-Egger. Results: Based on 10 single nucleotide polymorphisms distinctly predicting HDL-C in the CETP locus, we found that HDL-C was not associated with risk of AD (P >.7). Discussion: Our study does not support the role of HDL-C on risk of AD through HDL-C altered by CETP. This study does not rule out other mechanisms by which HDL-C affects risk of AD.",

keywords = "Cholesteryl ester transfer protein, Genetics, HDL-C, Instrumental variables, Single nucleotide polymorphisms",

author = "{ARUK Consortium} and {GERAD/PERADES, CHARGE, ADGC, EADI} and {International Genomics of Alzheimer's Project (IGAP)} and {ARUK Consortium} and {GERAD/PERADES, CHARGE, ADGC, EADI} and Peloso, {Gina M.} and {van der Lee}, {Sven J.} and R. Sims and {van der Lee}, {S. J.} and Naj, {A. C.} and C. Bellenguez and N. Badarinarayan and J. Jakobsdottir and Kunkle, {B. W.} and A. Boland and R. Raybould and Bis, {J. C.} and Martin, {E. R.} and B. Grenier-Boley and S. Heilmann-Heimbach and V. Chouraki and Kuzma, {A. B.} and K. Sleegers and M. Vronskaya and A. Ruiz and Graham, {R. R.} and R. Olaso and P. Hoffmann and Grove, {M. L.} and Vardarajan, {B. N.} and M. Hiltunen and N{\"o}then, {M. M.} and White, {C. C.} and Hamilton-Nelson, {K. L.} and J. Epelbaum and W. Maier and Choi, {S. H.} and Beecham, {G. W.} and C. Dulary and S. Herms and Smith, {A. V.} and Funk, {C. C.} and Derbois and Forstner, {A. J.} and S. Ahmad and H. Li and Boeve, {B. F.} and Carrasquillo, {M. M.} and Graff-Radford, {N. R.} and Pankratz, {V. S.} and Parisi, {J. E.} and Petersen, {R. C.} and N. Ertekin-Taner and Younkin, {S. G.} and Dickson, {D. W.}",

note = "Publisher Copyright: {\textcopyright} 2018 The Authors",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/j.dadm.2018.08.008",

language = "English (US)",

volume = "10",

pages = "595--598",

journal = "Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring",

issn = "2352-8729",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

AU - ARUK Consortium

AU - GERAD/PERADES, CHARGE, ADGC, EADI

AU - International Genomics of Alzheimer's Project (IGAP)

AU - ARUK Consortium

AU - GERAD/PERADES, CHARGE, ADGC, EADI

AU - Peloso, Gina M.

AU - van der Lee, Sven J.

AU - Sims, R.

AU - van der Lee, S. J.

AU - Naj, A. C.

AU - Bellenguez, C.

AU - Badarinarayan, N.

AU - Jakobsdottir, J.

AU - Kunkle, B. W.

AU - Boland, A.

AU - Raybould, R.

AU - Bis, J. C.

AU - Martin, E. R.

AU - Grenier-Boley, B.

AU - Heilmann-Heimbach, S.

AU - Chouraki, V.

AU - Kuzma, A. B.

AU - Sleegers, K.

AU - Vronskaya, M.

AU - Ruiz, A.

AU - Graham, R. R.

AU - Olaso, R.

AU - Hoffmann, P.

AU - Grove, M. L.

AU - Vardarajan, B. N.

AU - Hiltunen, M.

AU - Nöthen, M. M.

AU - White, C. C.

AU - Hamilton-Nelson, K. L.

AU - Epelbaum, J.

AU - Maier, W.

AU - Choi, S. H.

AU - Beecham, G. W.

AU - Dulary, C.

AU - Herms, S.

AU - Smith, A. V.

AU - Funk, C. C.

AU - Derbois,

AU - Forstner, A. J.

AU - Ahmad, S.

AU - Li, H.

AU - Boeve, B. F.

AU - Carrasquillo, M. M.

AU - Graff-Radford, N. R.

AU - Pankratz, V. S.

AU - Parisi, J. E.

AU - Petersen, R. C.

AU - Ertekin-Taner, N.

AU - Younkin, S. G.

AU - Dickson, D. W.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Introduction: There is conflicting evidence whether high-density lipoprotein cholesterol (HDL-C) is a risk factor for Alzheimer's disease (AD) and dementia. Genetic variation in the cholesteryl ester transfer protein (CETP) locus is associated with altered HDL-C. We aimed to assess AD risk by genetically predicted HDL-C. Methods: Ten single nucleotide polymorphisms within the CETP locus predicting HDL-C were applied to the International Genomics of Alzheimer's Project (IGAP) exome chip stage 1 results in up 16,097 late onset AD cases and 18,077 cognitively normal elderly controls. We performed instrumental variables analysis using inverse variance weighting, weighted median, and MR-Egger. Results: Based on 10 single nucleotide polymorphisms distinctly predicting HDL-C in the CETP locus, we found that HDL-C was not associated with risk of AD (P >.7). Discussion: Our study does not support the role of HDL-C on risk of AD through HDL-C altered by CETP. This study does not rule out other mechanisms by which HDL-C affects risk of AD.

AB - Introduction: There is conflicting evidence whether high-density lipoprotein cholesterol (HDL-C) is a risk factor for Alzheimer's disease (AD) and dementia. Genetic variation in the cholesteryl ester transfer protein (CETP) locus is associated with altered HDL-C. We aimed to assess AD risk by genetically predicted HDL-C. Methods: Ten single nucleotide polymorphisms within the CETP locus predicting HDL-C were applied to the International Genomics of Alzheimer's Project (IGAP) exome chip stage 1 results in up 16,097 late onset AD cases and 18,077 cognitively normal elderly controls. We performed instrumental variables analysis using inverse variance weighting, weighted median, and MR-Egger. Results: Based on 10 single nucleotide polymorphisms distinctly predicting HDL-C in the CETP locus, we found that HDL-C was not associated with risk of AD (P >.7). Discussion: Our study does not support the role of HDL-C on risk of AD through HDL-C altered by CETP. This study does not rule out other mechanisms by which HDL-C affects risk of AD.

KW - Cholesteryl ester transfer protein

KW - Genetics

KW - HDL-C

KW - Instrumental variables

KW - Single nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=85055648674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055648674&partnerID=8YFLogxK

U2 - 10.1016/j.dadm.2018.08.008

DO - 10.1016/j.dadm.2018.08.008

M3 - Article

AN - SCOPUS:85055648674

SN - 2352-8729

VL - 10

SP - 595

EP - 598

JO - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

JF - Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

ER -

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this